Company: SYRA
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-022023
Chunk: 8

Company: Syra Health Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 1
Chunk 8
---
 50,614 
  
    Other current assets 
     279,890  
     285,456 
  
    Right-of-use asset 
     89,621  
     - 
  
    Accounts payable 
     215,723  
     (250,060)
  
    Accounts payable, related parties 
     137,764  
     - 

    Accounts payable 
     137,764  
     - 

    Deferred revenue 
     125,000  
     6,108 
  
    Accrued expenses 
     (5,691) 
     110,628 
  
    Operating lease liability 
     (89,621) 
     (63,199)
  
    Net cash (used in) operating activities 
     (158,554) 
     (2,717,313)

    CASH FLOWS FROM INVESTING ACTIVITIES 

    Purchase of property and equipment 
     -  
     (11,111)
  
    Net cash used in investing activities 
     -  
     (11,111)

    CASH FLOWS FROM FINANCING ACTIVITIES 

    Proceeds received on exercise of warrants 
     14,800  
     2,469,150 
  
    Repayments on notes payable 
     (275,106) 
     (323,342)
  
    Net cash provided by/(used in) financing activities 
     (260,306) 
     2,145,808 

    NET CHANGE IN CASH AND CASH EQUIVALENTS 
     (418,860) 
     (582,616)
  
    CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 
     2,395,405  
     3,280,075 
  
    CASH AND CASH EQUIVALENTS AT END OF PERIOD 
    $1,976,545  
    $2,697,459 

    SUPPLEMENTAL INFORMATION: 

    Interest paid 
    $8,992  
    $10,072 
  
    Income taxes paid 
    $-  
    $- 
  
    NON-CASH INVESTING AND FINANCING ACTIVITIES: 

    Conversion of Class B common stock to Class A common stock 
    $2,333